Capital Pro-Égaux Inc., through its wholly owned subsidiary Technique
d'usinage Sinlab Inc, files a court action for patent infringement
LACHENAIE, QC, June 29 /CNW Telbec/ - Capital Pro-Égaux Inc. (the "Company") reports that further to the filing of a notice against BioCad Medical Inc on July 13, 2009 through its wholly owned subsidiary Technique d'usinage Sinlab Inc., a COURT ACTION has been filed on June 25th, 2010 by Technique d'usinage Sinlab Inc against BioCad Medical Inc, a Québec city based company wholly owned by Nobel Biocare, for patent infringement of the "Company" Canadian patent 2,575,964 issued on 27th of May 2008.
About Pro-Égaux Inc.
Pro-Égaux through its wholly owned subsidiary, Technique d'usinage Sinlab Inc., is a company based in Lachenaie, Quebec, specializing mainly in the conception and design of titanium products to be used in the dental prosthesis restoration industry.
"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."
For further information: Pierre Désormeau, President, Capital Pro-Égaux Inc., Tel.: (514) 616-0612, Fax: (450) 226-1923, [email protected]
Share this article